Susan Hasty, Publisher
Table of Contents . . . April 6th, 1998Non-Subscriber - Summaries Only
Cancer Vaccines (HPV16) - Protein Based Vaccines Protect Against HPV16-Induced Tumor
Cancer Gene Therapy - Mutant Activated G(alpha)S Inhibits Tumorigenesis in Breast Cancer Model
DNA Immunization - Genetically Modified Dendritic Cells Elicit Antitumor Responses
Immunology (Vectors) - Transient Immunosuppression Allows Readministration of AAV Vectors
Brain Cancer - HealthONE Announces New Cancer Treatment
Breast Cancer - Study Sees Limited Need for Cancer Test
Cancer Gene Therapy (Conference News) - Phase I Trial Results of E1A Gene Therapy Reported
Cancer Therapies - Investigational Radioimmunotherapy for Non-Hodgkin's Lymphoma Data Reported
Drug Development - Approval Sought for Cancer and Diabetes Drugs
Environment - WHO Program Will Oversee Endocrine Disruptors
Epidemiology - Report Shows Progress in Controlling Cancer
Helicobacter pylori - Researchers Discover Ways Ulcer/Cancer Bug Can Trigger Disease
Industry News (Joint Venture) - Anti-Cancer Compounds Preclinical Development Initiated
Industry News (Joint Venture) - Gene Expression Database Under Expanded Collaboration
Pediatrics - High Leukemia Not From Nuclear Accident
Prognostics (Conference News) - Predicting Therapy Success Rates For Patients - Before Treatment
Prostate Cancer - Enrollment Completed in EchoGen Emulsion Phase 3 Trial
Prostate Cancer - Vaccine Shows Promise in Clinical Trials
Prostate Cancer (Pathogenesis) - Genetic Switch May Yield Map of Cancer Machinery, Targets for Drugs
Stomach Cancer - Susceptibility Gene for Cancer Found
Transplantation - Lisofylline Trial of Among Cancer Patients Undergoing BMT Reported
Cancer Gene Therapy - "Engineering Immune Effector Cells to Target the HER-2/neu Breast Cancer Antigen."
Cancer Gene Therapy - "Tumour Therapy in Mice Using Adenovirus Vectors Expressing Human TNF alpha."
Cancer Immunotherapy - "Role of Urokinase-Type Plasminogen Activator in Local Immunotherapy."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.